Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RYTHM, Inc.AGFY · Entity 2092 | Chief Science Officer | December 03, 2024 | December 06, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RYTHM, Inc.
Report date December 03, 2024 · Filed December 06, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2024-12-03 transaction · row 13
13 source rows · reconciled sequenceRow 1 · 2024-12-03 · Sale · Disposed 2,081 · Balance 11,517 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.605 to $33.25, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (13) to this Form 4. Row 2 · 2024-12-03 · Sale · Disposed 1,514 · Balance 10,003 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.26 to $34.19, inclusive. Row 3 · 2024-12-03 · Sale · Disposed 1,093 · Balance 8,910 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.26 to $35.25, inclusive. Row 4 · 2024-12-03 · Sale · Disposed 865 · Balance 8,045 F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.32 to $36.30, inclusive. Row 5 · 2024-12-03 · Sale · Disposed 1,160 · Balance 6,885 F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.40 to $37.35, inclusive. Row 6 · 2024-12-03 · Sale · Disposed 575 · Balance 6,310 F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.40 to $38.385, inclusive. Row 7 · 2024-12-03 · Sale · Disposed 1,100 · Balance 5,210 F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.425 to $39.02, inclusive. Row 8 · 2024-12-03 · Sale · Disposed 2,551 · Balance 2,659 F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.41, inclusive. Row 9 · 2024-12-03 · Sale · Disposed 1,173 · Balance 1,486 F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.59 to $41.50, inclusive. Row 10 · 2024-12-03 · Sale · Disposed 400 · Balance 1,086 F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.715 to $42.68, inclusive. Row 11 · 2024-12-03 · Sale · Disposed 572 · Balance 514 F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.24, inclusive. Row 12 · 2024-12-03 · Sale · Disposed 200 · Balance 314 F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.14 to $45.00, inclusive. Row 13 · 2024-12-03 · Sale · Disposed 314 · Balance 0 F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.20 to $46.00, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.605 to $33.25, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (13) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.26 to $34.19, inclusive.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.26 to $35.25, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.32 to $36.30, inclusive.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.40 to $37.35, inclusive.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.40 to $38.385, inclusive.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.425 to $39.02, inclusive.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.41, inclusive.
F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.59 to $41.50, inclusive.
F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.715 to $42.68, inclusive.
F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.24, inclusive.
F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.14 to $45.00, inclusive.
F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.20 to $46.00, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 314 | $45.62 | $14,323.99 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 13 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.20 to $46.00, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 200 | $44.57 | $8,914.00 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 12 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314 F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.14 to $45.00, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 572 | $43.14 | $24,674.76 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 11 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514 F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.24, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 400 | $42.12 | $16,847.80 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 10 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,086 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.715 to $42.68, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 1,173 | $40.07 | $46,998.59 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 9 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,486 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.59 to $41.50, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 2,551 | $39.98 | $101,985.15 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 8 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,659 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.41, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 1,100 | $38.78 | $42,656.79 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 7 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,210 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.425 to $39.02, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 575 | $37.66 | $21,656.05 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 6 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,310 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.40 to $38.385, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 1,160 | $37.22 | $43,175.55 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 5 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,885 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.40 to $37.35, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 865 | $35.80 | $30,966.14 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 4 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,045 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.32 to $36.30, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 1,093 | $34.74 | $37,972.90 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 3 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,910 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.26 to $35.25, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 1,514 | $33.66 | $50,965.48 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 2 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,003 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.26 to $34.19, inclusive. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 02:00 UTC | RYTHM, Inc. AGFY · Entity 2092 | SaleCommon Stock | 2,081 | $32.66 | $67,956.93 |
DisclosureSEC source: 0001213900-24-106156 · ownership.xml · nonDerivative · entry 1 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,517 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.605 to $33.25, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (13) to this Form 4. Read SEC document |
| November 28, 2024 Filed Dec 2, 2024 22:41 UTC | RYTHM, Inc. AGFY · Entity 2092 | Exercise / conversionRestricted Stock Unit · Derivative | 13,597 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-104688 · ownership.xml · derivative · entry 2 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,597 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Shares of the issuer's common stock were issued to the reporting person upon the vesting of restricted stock units on November 28, 2024. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the issuer. F3 · derivative.exercise_date: On November 28, 2023, the reporting person was granted 13,597 restricted stock units under the Agrify Corporation 2022 Omnibus Equity Incentive Plan. All of the restricted stock units vested on November 28, 2024. F3 · derivative.expiration_date: On November 28, 2023, the reporting person was granted 13,597 restricted stock units under the Agrify Corporation 2022 Omnibus Equity Incentive Plan. All of the restricted stock units vested on November 28, 2024. Read SEC document |
| November 28, 2024 Filed Dec 2, 2024 22:41 UTC | RYTHM, Inc. AGFY · Entity 2092 | Exercise / conversionCommon Stock | 13,597 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-24-104688 · ownership.xml · nonDerivative · entry 1 Kessler David Aaron · CIK 0001941459 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of the issuer's common stock were issued to the reporting person upon the vesting of restricted stock units on November 28, 2024. Read SEC document |
| April 24, 2024 Filed Apr 26, 2024 20:01 UTC | RYTHM, Inc. AGFY · Entity 2092 | GrantRestricted Stock Unit · Derivative | 54,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-036617 · ownership.xml · derivative · entry 1 Kessler David Aaron · CIK 0001941459 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,611 Underlying: Common Stock · 54,611 shares Expires not disclosed F1 · security: Grant of restricted stock units under the Agrify Corporation 2022 Omnibus Equity Incentive Plan (the "Plan"). The restricted stock units were granted in lieu of cash compensation that would otherwise be owed to the reporting person. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the issuer. F3 · derivative.exercise_date: 100% of the restricted stock unit will vest on April 24, 2025, subject to obtaining shareholder approval for an increase in shares available under the Plan sufficient to grant the units, and subject to the reporting person's continuous service through such vesting date. F3 · derivative.expiration_date: 100% of the restricted stock unit will vest on April 24, 2025, subject to obtaining shareholder approval for an increase in shares available under the Plan sufficient to grant the units, and subject to the reporting person's continuous service through such vesting date. Read SEC document |
| November 28, 2023 Filed Nov 30, 2023 21:30 UTC | RYTHM, Inc. AGFY · Entity 2092 | GrantRestricted Stock Unit · Derivative | 203,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-091487 · ownership.xml · derivative · entry 1 Kessler David Aaron · CIK 0001941459 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,961 Underlying: Common Stock · 203,961 shares Expires not disclosed F1 · security: Grant of restricted stock units under the Agrify Corporation 2022 Omnibus Equity Incentive Plan (the "Plan"). F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the issuer. F3 · derivative.exercise_date: 100% of the restricted stock units will vest on November 28, 2024, subject to obtaining shareholder approval for an increase in shares available under the Plan sufficient to grant the units, and subject to the reporting person's continuous service through such vesting date. F3 · derivative.expiration_date: 100% of the restricted stock units will vest on November 28, 2024, subject to obtaining shareholder approval for an increase in shares available under the Plan sufficient to grant the units, and subject to the reporting person's continuous service through such vesting date. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:30 UTC | RYTHM, Inc. AGFY · Entity 2092 | GrantRestricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-061909 · ownership.xml · derivative · entry 1 Kessler David Aaron · CIK 0001941459 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · security: Grant of restricted stock units under to the Agrify Corporation 2022 Omnibus Equity Incentive Plan. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the issuer. F3 · derivative.exercise_date: The restricted stock units will vest in three equal installments on September 30, 2023, September 30, 2024 and September 30, 2025, subject to the reporting person's continuous service through each applicable vesting date. F3 · derivative.expiration_date: The restricted stock units will vest in three equal installments on September 30, 2023, September 30, 2024 and September 30, 2025, subject to the reporting person's continuous service through each applicable vesting date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:30 UTC | RYTHM, Inc. AGFY · Entity 2092 | GrantRestricted Stock Unit · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-046367 · ownership.xml · derivative · entry 1 Kessler David Aaron · CIK 0001941459 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · security: Grant of restricted stock units under to the Agrify Corporation 2022 Omnibus Equity Incentive Plan. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the issuer. F3 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 8, 2023, August 8, 2024 and August 8, 2025, subject to the reporting person's continuous service through each applicable vesting date. F3 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 8, 2023, August 8, 2024 and August 8, 2025, subject to the reporting person's continuous service through each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.